The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years

Abstract

Mortality in Parkinson's disease remains increased despite low dose levodopa-carbidopa therapy and no additional benefit was gained from early use of bromocriptine. Duration of disease was similar to that in the era before levodopa.